Skip to main content

SOLIRIS

NDC 25682-001 · Alexion Pharmaceuticals Inc.

Generic nameECULIZUMAB
Dosage formINJECTION, SOLUTION, CONCENTRATE
RouteINTRAVENOUS
Active ingredient(s)ECULIZUMAB
Strength300 mg/30mL
Pharmacologic classComplement Inhibitor [EPC], Complement Inhibitors [MoA]
Marketing categoryBLA

Packages

25682-001-01 — 1 VIAL in 1 CARTON (25682-001-01) / 30 mL in 1 VIAL

Billed under HCPCS

J1299 — Injection, eculizumab, 2 mg Medicare Part B payment limit (ASP + 6%): $43.76

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

51759-208 — Eculizumab-aagh, 55513-180 — eculizumab-aeeb

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q4 (October 2026 release). All data sources · How to read the labels

Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources